搜尋結果
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 7 小時前Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term ...
VC firm Antler's CEO says Asia presents 'biggest opportunity' in the world for growth
TechCrunch· 7 小時前Asia’s startup ecosystem hasn’t been doing well in the past couple years, as everything from ...
Council Post: Superstar Strategy: 19 Tech Leaders Reveal Big Tech’s Top ‘Secrets’
Forbes· 4 日前Launching a startup that survives beyond five years is an accomplishment, especially in the ...
Hong Kong proves ideal base for Rainbow Genomics to expand accredited medical services
South China Morning Post· 16 小時前Hong Kong Trade Development Council figures show the total of new businesses in the city grew ...
Samsung faces probe after two chip workers exposed to radiation, authorities say
CNBC· 2 日前The two patients, who are hospitalized, were showing "abnormal" symptoms of radiation ...
Extreme Weather Already Threatening, Likely Worse In 2025, Expert Says
Forbes· 6 日前As if this year’s extreme weather wasn’t enough already, we can expect worse next year, with ...
The Business Owners Fiercely Guarding Their Time To Protect Creativity
Forbes· 5 日前Burnout, email overload and meetings bloat all feature in Microsoft and LinkedIn’s new Work ...
Merck To Pay as Much as $3 Billion for Eye Treatment Startup
Bloomberg· 2 日前Have a confidential tip for our reporters? Merck & Co. restocked its cabinet of eye treatments ...
South Korea investigating two Samsung workers exposed to radiation
Reuters· 2 日前The incident took place at Samsung's plant in Giheung, south of Seoul, on Monday, and the ...
Merck to buy eye-focused drug developer EyeBio for as much as $3 bln
Reuters· 2 日前, opens new tab on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 ...